Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析

◆英語タイトル:Ergomed Plc (ERGO) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDPH191030FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:Pharmaceuticals and Healthcare
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥76,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥115,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Ergomed Plc (Ergomed) is a provider of drug development and clinical research services. The company offers clinical development, trial management, pharmacovigilance, medical monitoring and writing, project management and monitoring, regulatory affairs, quality, data and site management, clinical research outsourcing services. It provides services in the therapeutic areas of orphan drug development, oncology, hematology, allergy, respiratory and neurology. Ergomod serves pharmaceutical, biotechnology and generic companies. The company has operational presence in the UK, Poland, Germany, Bosnia, Croatia, India, Serbia, the Netherlands, the Czech Republic, Russia, Switzerland, Ukraine, Taiwan, the UAE and the US. Ergomed is headquartered in Guildford, Surrey, the UK.

Ergomed Plc Key Recent Developments

Mar 23,2021: 23 Mar 2021 Audited Full Year Results for the year ended 31 December
Mar 23,2021: ERGOMED: Audited full year results
Sep 22,2020: Ergomed interim results for the six months ended 30 June 2020
Jul 21,2020: Ergomed H1 2020 Trading Update

This comprehensive SWOT profile of Ergomed Plc provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Ergomed Plc including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Ergomed Plc – Key Information
Ergomed Plc – Overview
Ergomed Plc – Key Employees
Ergomed Plc – Key Employee Biographies
Ergomed Plc – Key Operational Heads
Ergomed Plc – Major Products and Services
Ergomed Plc – History
Ergomed Plc – Company Statement
Ergomed Plc – Locations And Subsidiaries
Ergomed Plc
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Ergomed Plc – Business Description
Ergomed Plc – Corporate Strategy
Ergomed Plc – SWOT Analysis
SWOT Analysis – Overview
Ergomed Plc – Strengths
Ergomed Plc – Weaknesses
Ergomed Plc – Opportunities
Ergomed Plc – Threats
Ergomed Plc – Key Competitors

Section 3 – Company Financial Performance Charts

Ergomed Plc – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Ergomed Plc, Key Information
Ergomed Plc, Key Ratios
Ergomed Plc, Share Data
Ergomed Plc, Major Products and Services
Ergomed Plc, History
Ergomed Plc, Key Employees
Ergomed Plc, Key Employee Biographies
Ergomed Plc, Key Operational Heads
Ergomed Plc, Other Locations
Ergomed Plc, Subsidiaries
Ergomed Plc, Key Competitors
Ergomed Plc, SWOT Analysis
Ergomed Plc, Ratios based on current share price
Ergomed Plc, Annual Ratios
Ergomed Plc, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Ergomed Plc (ERGO):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Saras S.p.A. (SRS):電力:M&Aディール及び事業提携情報
    Summary Saras S.p.A. (Saras) is crude oil refiner and operates refining, marketing, power generation and wind power businesses. The company’s major refinery is Sarroch refinery, on the Southwestern coast of Sardinia. Saras is also active in the production and sale of electricity, and offers industri …
  • Banco Bradesco SA:企業の戦略・SWOT・財務情報
    Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report Summary Banco Bradesco SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Concordia International Rx UK Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Concordia International Rx UK Ltd (Concordia International), formerly Amdipharm Mercury Company Ltd, a subsidiary of Concordia International Corp, is a manufacturer of pharmaceutical products and orphan drugs. The company’s products include acetazolamide, adenosine, adrenaline acid tartrate, …
  • Motif BioSciences Inc-製薬・医療分野:企業M&A・提携分析
    Summary Motif BioSciences Inc (Motif), a subsidiary of Motif Bio Plc is a clinical stage biopharmaceutical company that manufactures novel antibiotics designed to treat life-threatening infections caused by multi-drug resistant bacteria. The company’s product programs include MTF-001, iclaprim, and …
  • Axpo Holding AG:企業の戦略的SWOT分析
    Axpo Holding AG - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servic …
  • Longfor Group Holdings Limited:企業の戦略・SWOT・財務情報
    Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report Summary Longfor Group Holdings Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Arcam AB:企業の戦略的SWOT分析
    Arcam AB - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Step Pharma SAS:製薬・医療:M&Aディール及び事業提携情報
    Summary Step Pharma SAS (Step Pharma) is a biotechnology company that strives to discover and develop proprietary small molecule medicines for the treatment of auto-immune diseases. The company is developing a new class of oral nucleotide synthesis inhibitors against cytidine triphosphate synthase 1 …
  • Eunice Kennedy Shriver National Institute of Child Health and Human Development-製薬・医療分野:企業M&A・提携分析
    Summary Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a subsidiary of National Institutes of Health is a research institute that conducts and supports laboratory research, clinical trials, and epidemiological studies. The institute conducts research in the …
  • Parker Drilling Co (PKD):企業の財務・戦略的SWOT分析
    Parker Drilling Co (PKD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Abbott Laboratories (ABT):医療機器:M&Aディール及び事業提携情報
    Summary Abbott Laboratories (Abbott) develops, manufactures, and sells a diversified range of healthcare products including drugs, diagnostics, branded generics, and vascular and nutritional products. The company’s products comprise specialized medicines; medical diagnostic instruments and tests; mi …
  • East African Breweries Limited:企業の戦略・SWOT・財務情報
    East African Breweries Limited - Strategy, SWOT and Corporate Finance Report Summary East African Breweries Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Talwalkars Better Value Fitness Ltd (TALWALKARS):企業の財務・戦略的SWOT分析
    Talwalkars Better Value Fitness Ltd (TALWALKARS) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key s …
  • Globeimmune Inc (GBIM):企業の財務・戦略的SWOT分析
    Summary Globeimmune Inc (Globeimmune) is a biopharmaceutical company that develops therapeutic products for treatment of cancer and infectious diseases. The company provides products for infectious disease and oncology. It offers oncology products such as GI-4000, GI-6207 and GI-6301. Globeimmune pr …
  • Endo International Plc (ENDP):企業の財務・戦略的SWOT分析
    Endo International Plc (ENDP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Inpex Corp (1605):石油・ガス:M&Aディール及び事業提携情報
    Summary Inpex Corp (Inpex) is an integrated energy company. It explores for, develops and produces oil and natural gas from its assets in domestic and international regions. The company markets crude oil, condensate, natural gas, and LNG. Inpex has working interest in various upstream projects in Eu …
  • Alzheimer’s Drug Discovery Foundation:製薬・医療:M&Aディール及び事業提携情報
    Summary Alzheimer's Drug Discovery Foundation (ADDF), formerly Institute for the Study of Aging is a drug discovery foundation. The foundation offers funds for drug discovery and development research programs in the field of Alzheimer’s disease, related dementias and cognitive aging. It offers servi …
  • Interferie S.A.:企業の戦略・SWOT・財務情報
    Interferie S.A. - Strategy, SWOT and Corporate Finance Report Summary Interferie S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Lamar Advertising Company (LAMR):企業の財務・戦略的SWOT分析
    Lamar Advertising Company (LAMR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • VeriSign Inc (VRSN):企業の財務・戦略的SWOT分析
    VeriSign Inc (VRSN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆